ALIVUS LIFE SCIENCES
Back to Balance Sheet
|
ALIVUS LIFE SCIENCES Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹470 Cr | ₹439 Cr | ₹1,015 Cr | ₹747 Cr | ₹1,445 Cr |
What is the latest Total Current Liabilities ratio of ALIVUS LIFE SCIENCES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹470 Cr |
| Mar2024 | ₹439 Cr |
| Mar2023 | ₹1,015 Cr |
| Mar2022 | ₹747 Cr |
| Mar2021 | ₹1,445 Cr |
How is Total Current Liabilities of ALIVUS LIFE SCIENCES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹470 Cr | 7.15 | |
| Mar2024 | ₹439 Cr | -56.77 | |
| Mar2023 | ₹1,015 Cr | 35.90 | |
| Mar2022 | ₹747 Cr | -48.32 | |
| Mar2021 | ₹1,445 Cr | - | |
Compare Total Current Liabilities of peers of ALIVUS LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALIVUS LIFE SCIENCES | ₹12,083.5 Cr | 6.2% | 8.6% | -14.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,645.0 Cr | 2.9% | 3.6% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,625.0 Cr | 0.6% | -4.5% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,415.0 Cr | 2.1% | -0.4% | 31.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,664.0 Cr | 2.2% | -0.4% | 6.2% | Stock Analytics | |
| CIPLA | ₹100,480.0 Cr | 0.4% | -6.2% | -19.4% | Stock Analytics | |
ALIVUS LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALIVUS LIFE SCIENCES | 6.2% |
8.6% |
-14.5% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses